marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-07-2024
Intellia Therapeutics General and Administrative Expenses 2011-2024 | NTLA
Annual General and Administrative Expenses Intellia Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116 M | 90.3 M | 71.1 M | 44.2 M | 41.1 M | 32.2 M | 28 M | 16.8 M | 8.28 M | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 116 M | 8.28 M | 49.8 M |
Quarterly General and Administrative Expenses Intellia Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 30.5 M | 31.8 M | 31.1 M | - | 29.4 M | 30.7 M | 27.4 M | - | 22.1 M | 22.1 M | 22.4 M | - | 18.7 M | 16.7 M | 13.6 M | 10.8 M | 10.6 M | 11.5 M | 11.3 M | 8.98 M | 8.43 M | 13.1 M | 10.5 M | 8.71 M | 8.27 M | 7.8 M | 7.41 M | 10.2 M | 5.71 M | 6.37 M | 5.73 M | 5.12 M | 4.7 M | 3.73 M | 3.25 M | 2.81 M | 1.53 M | 2.83 M | 1.11 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 31.8 M | 1.11 M | 13 M |